Dosage and protocol evidence
Each card states what the quantities are based on. A third-party or animal schedule is not a validated human dose.
Animal StudyIntraperitoneal in miceTwice daily in study
Mice in the original ERR agonist experiments
50 mg/kg intraperitoneally twice daily was used in repeated mouse experiments; a separate acute exercise test used a single 50 mg/kg exposure
This is a murine experimental exposure, not a human-equivalent dose. No human administration study supports conversion of the quantity or route.
View sourceEvidence summary
A synthetic oestrogen-related receptor agonist often grouped with research peptides despite being a small molecule. Evidence remains preclinical.
Protocol basis
Only laboratory and animal study designs are available, so the evidence page does not invent a human schedule.
What remains uncertain
Human pharmacokinetics, safety, tolerability, formulation and effectiveness are unknown.
Warnings and contraindications
No human clinical administration study or validated human regimen was identified.
Rodent exposures cannot be converted into human dosing.
The compound is not a peptide and has no authorised formulation.